Related Experiment Video

Updated: Mar 19, 2026

RhoC GTPase Activation Assay
09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

13.1K

Role of G protein-coupled receptor kinase 2 in tumoral angiogenesis

Verónica Rivas1, Laura Nogués1, Clara Reglero1

  • 1Departamento de Biología Molecular and Centro de Biología Molecular "Severo Ochoa" (Consejo Superior de Investigaciones Científicas - Universidad Autónoma de Madrid); Universidad Autónoma de Madrid; Madrid, Spain; Instituto de Investigación Sanitaria La Princesa; Madrid, Spain.

Molecular & Cellular Oncology
|June 17, 2016
PubMed

Insights

Decreased G protein-coupled receptor kinase 2 (GRK2) in blood vessel cells promotes tumor growth by affecting pericytes, leading to hypoxia and immune cell infiltration, impacting cancer progression.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Downregulation of G protein-coupled receptor kinase 2 (GRK2) in endothelial cells is linked to the tumoral angiogenic switch.
  • GRK2 plays a role in vascular stabilization and remodeling signaling pathways.

Purpose of the Study:

  • To investigate the role of GRK2 in tumor angiogenesis and growth.
  • To understand how GRK2 downregulation affects the tumor microenvironment and cell interactions.

Main Methods:

  • Utilized cell and animal models to study the effects of altering GRK2 dosage.
  • Examined the impact of decreased GRK2 expression on endothelial cells, pericytes, hypoxia, and macrophage infiltration in tumors.

Main Results:

  • Reduced GRK2 expression in endothelial cells accelerated tumor growth in mice.
  • Decreased GRK2 impaired pericyte ensheathment of vessels, promoting tumor hypoxia and macrophage infiltration.
  • GRK2 kinase acts as a hub in signaling pathways crucial for vascular integrity.

Conclusions:

  • GRK2 downregulation in endothelial cells is a key event in tumor angiogenesis and progression.
  • Further research is needed to elucidate the mechanisms of GRK2 decrease in cancer and its modulation of tumor microenvironment interactions.
Keywords:
ALK1 signalingGRK2PDGF-BBangiogenesiscancertumor-associated macrophagevascular maturation

More Related Videos

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors09:04

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

Published on: March 15, 2016

10.3K
Strategic Endothelial Cell Tube Formation Assay: Comparing Extracellular Matrix and Growth Factor Reduced Extracellular Matrix08:46

Strategic Endothelial Cell Tube Formation Assay: Comparing Extracellular Matrix and Growth Factor Reduced Extracellular Matrix

Published on: August 14, 2016

14.0K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.2K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
19.1K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.6K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.9K